Clinical Trial Update: A Study to Test the Safety and Effectiveness of an Investigational Vaccine in Infants (V419-002) [Phase 2]

View source ↗

Summary

Merck's investigational vaccine V419-002 completed Phase 2 testing in infants, evaluating safety and effectiveness for bacterial and viral infections. The trial…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Infections
• Viral Infections

Drugs mentioned

• V419-002

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Bacterial Infections; Virus Diseases | Phase 2 | Status: COMPLETED